California Substance Abuse Research Consortium (SARC) Meeting, Spring 2003

Table of Contents

SARC Supplement, Number 2

May 2004

Editor’s Introduction: California Substance Abuse Research Consortium, Spring 2003 —  Richard Rawson, Ph.D.; Darren Urada, Ph.D. & Beth Finnerty, M.P.H.

California Substance Abuse Research Consortium, May 2003:  Update on Recent Substance Abuse Trends  —  Beth A. Finnerty, M.P.H.

Pilot-Testing a Statewide Outcome Monitoring System:  Overview of the California Treatment Outcome Project (CALTOP) — Elizabeth Evans, M.A. & Yih-Ing Hser, Ph.D.

Diffusion of Substance Abuse Treatment: Will Buprenorphine be a Success?  — Walter Ling, M.D.; Jerry Cunningham-Rathner & Richard Rawson, Ph.D.

Buprenorphine in Treatment of Opiate Dependence:  Its Pharmacology and Social Context of Use in the US — Donald R. Wesson, M.D.

Evolving Use of Buprenorphine in the Treatment of Addiction — Judith Martin, M.D.

Counseling Buprenorphine Patients: Information and Treatment Approaches for Counselors — Michael J. McCann, M.A.

California Drug Courts:  A Methodology for Determining Costs and Avoided Costs — Francine Byrne, M.A.; Richard Schauffler, M.A.; Lisa Lightman, M.A.;  Michael Finigan, Ph.D. & Shannon Carey, Ph.D.

Alcohol and Violence: Connections, Evidence and Possibilities for Prevention — Robert Nash Parker, Ph.D.

Evaluation of the Substance Abuse and Crime Prevention Act:  Treatment Clients and Program Types During the First Year of Implementation — Elizabeth Evans, M.A. & Douglas Longshore, Ph.D.

When You Assume… The Reality of Implementing a Legally Mandated Substance Abuse Treatment Program — Deane Wiley, Ph.D. ; Martha Beattie, Ph.D. ; Hung Nguyen, M.S. ; Katherine Puckett, Ph.D.; Kakoli Banerjee, Ph.D. & Winnie Poon

COVER ART — Continental Divide by Rori Ranch Productions